Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v47-EN Version v28-FR
Language English French
Date Updated 2018-06-26 2018-04-17
Drug Identification Number 02238525 02238525
Brand name HP-PAC HP-PAC
Common or Proper name LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN
Company Name TAKEDA PHARMACEUTICALS AMERICA INC TAKEDA PHARMACEUTICALS AMERICA INC
Ingredients AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN
Strength(s) 500MG 30MG 500MG 500MG 30MG 500MG
Dosage form(s) KIT CAPSULE CAPSULE (SUSTAINED-RELEASE) TABLET KIT CAPSULE CAPSULE (SUSTAINED-RELEASE) TABLET
Route of administration ORAL ORAL
Packaging size Blister pack Blister pack
ATC code A02BD A02BD
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2018-04-30
Actual start date 2018-05-07
Estimated end date 2018-05-30
Actual end date 2018-06-25
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments